Healthcare provider profile · identity verified

Angela Miller

Nurse Practitioner · MIDLAND, MI · NPI 1649657164

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	404	55
Levothyroxine Sodium	Levothyroxine Sodium	255	40
Omeprazole	Omeprazole	208	28
Amlodipine Besylate	Amlodipine Besylate	171	30
Buspirone Hcl	Buspirone Hcl	166	31
Donepezil Hcl	Donepezil Hcl	163	22
Pantoprazole Sodium	Pantoprazole Sodium	143	25
Mirtazapine	Mirtazapine	141	26
Losartan Potassium	Losartan Potassium	138	20
Sertraline Hcl	Sertraline Hcl	137	24
Tamsulosin Hcl	Tamsulosin Hcl	136	25
Quetiapine Fumarate	Quetiapine Fumarate	126	26
Metoprolol Tartrate	Metoprolol Tartrate	125	22
Furosemide	Furosemide	121	22
Eliquis	Apixaban	120	17
Potassium Chloride	Potassium Chloride	120	24
Clopidogrel	Clopidogrel Bisulfate	117	14
Duloxetine Hcl	Duloxetine Hcl	110	15
Lisinopril	Lisinopril	108	18
Gabapentin	Gabapentin	104	22
Famotidine	Famotidine	96	12
Metoprolol Succinate	Metoprolol Succinate	94	14
Hydrochlorothiazide	Hydrochlorothiazide	93	15
Olanzapine	Olanzapine	90	14
Escitalopram Oxalate	Escitalopram Oxalate	87	13
Trazodone Hcl	Trazodone Hcl	83	12
Levetiracetam	Levetiracetam	68	11
Simvastatin	Simvastatin	60	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	58	suppressed
Citalopram Hbr	Citalopram Hydrobromide	56	suppressed
Metformin Hcl	Metformin Hcl	54	11
Memantine Hcl	Memantine Hcl	51	suppressed
Risperidone	Risperidone	51	suppressed
Divalproex Sodium	Divalproex Sodium	46	suppressed
Lorazepam	Lorazepam	44	12
Meloxicam	Meloxicam	43	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	43	suppressed
Atenolol	Atenolol	42	suppressed
Lamotrigine	Lamotrigine	42	suppressed
Prazosin Hcl	Prazosin Hcl	42	suppressed
Montelukast Sodium	Montelukast Sodium	40	suppressed
Carvedilol	Carvedilol	39	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	36	29
Xarelto	Rivaroxaban	36	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	35	suppressed
Hydralazine Hcl	Hydralazine Hcl	35	suppressed
Ezetimibe	Ezetimibe	34	suppressed
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Finasteride	Finasteride	32	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	30	suppressed
Fluticasone Propionate	Fluticasone Propionate	30	suppressed
Tramadol Hcl	Tramadol Hcl	29	14
Enalapril Maleate	Enalapril Maleate	28	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	28	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	27	suppressed
Alcohol Swabs	Alcohol Antiseptic Pads	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	20
Lacosamide	Lacosamide	25	suppressed
Propranolol Hcl	Propranolol Hcl	25	suppressed
Azithromycin	Azithromycin	24	19
Sucralfate	Sucralfate	24	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Glipizide Er	Glipizide	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Clonazepam	Clonazepam	21	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	21	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	20	suppressed
Jardiance	Empagliflozin	20	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	20	suppressed
Prednisone	Prednisone	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Clozapine	Clozapine	18	suppressed
Latanoprost	Latanoprost	18	suppressed
Memantine Hcl Er	Memantine Hcl	18	suppressed
Bupropion Hcl Sr	Bupropion Hcl	17	suppressed
Bethanechol Chloride	Bethanechol Chloride	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Glipizide	Glipizide	16	suppressed
Loperamide	Loperamide Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Torsemide	Torsemide	16	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Amiodarone Hcl	Amiodarone Hcl	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Exemestane	Exemestane	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	14	14
Propranolol Hcl Er	Propranolol Hcl	14	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	14	suppressed
Baclofen	Baclofen	13	suppressed
Digoxin	Digoxin	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Novolog Flexpen	Insulin Aspart	13	suppressed
Phenytek	Phenytoin Sodium Extended	13	suppressed
Pilocarpine Hcl	Pilocarpine Hcl	13	suppressed
Primidone	Primidone	13	suppressed
Valsartan	Valsartan	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Buprenorphine	Buprenorphine	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	11
Esomeprazole Magnesium	Esomeprazole Magnesium	12	suppressed
Nystatin	Nystatin	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Tizanidine Hcl	Tizanidine Hcl	12	suppressed
Trimethoprim	Trimethoprim	12	suppressed
Alprazolam	Alprazolam	11	suppressed
Caplyta	Lumateperone Tosylate	11	suppressed
Glycopyrrolate	Glycopyrrolate	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Trintellix	Vortioxetine Hydrobromide	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error